Ming Cheah
Biotech Investor - Goldman Sachs Life Sciences Investing
San Francisco Bay Area
Invests in
Sectors:
Locations:
Min Investment:
$0.00Max Investment:
$0.00Target Investment:
$0.00
Skills
Education
Lists including Ming
Work Experience
2022
Vice President - Life Sciences Investing
2022
Focused on investments in private-stage, emerging therapeutics companies
2024
Board Member
2024
2024
Board Observer
2024
2023
Board Observer
2023
Board Observer
2023
2020 - 2022
Principal
2020 - 2022
Investments: Plexium, Exscientia (NAS: EXAI), Vigil Neuro (NAS: VIGL), Obsidian Therapeutics, HotSpot Therapeutics
2022 - 2022
Board Observer
2022 - 2022
2022 - 2022
Board Observer
2022 - 2022
2021 - 2022
Board Observer
2021 - 2022
2016 - 2020
Business Development and Competitive Intelligence
2016 - 2020
Led search and evaluation activities for early and clinical stage oncology assets Led teams with direct reports and large cross-functional teams to advise clinical development and commercial strategies for multiple drugs in oncology and neuroscience. Conducted competitive intelligence, market research and forecasting to inform strategic planning.